background image

Paid Clinical Trials Billings

Discover 140 paid clinical trials in Billings, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Lomustine with Temozolomide & Radiation

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Billings MT, Bozeman MT, Rapid City SD, Logan UTshow 269 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Magnetic Resonance Imaging

Photon Beam Radiation Therapy

Questionnaire Administration

Temozolomide

INBRX-106 & Pembrolizumab

Recruiting
PHASE2
PHASE3

Sponsor:

Inhibrx Biosciences, Inc

Location:

Billings MT, Portland OR, Omaha NE, Santa Fe NMshow 18 more

Code:

NCT06295731

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

INBRX-106

Pembrolizumab

Surgery vs. Treatment

Recruiting
PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Billings MT, Cody WY, Bozeman MT, Great Falls MTshow 180 more

Code:

NCT06632327

Conditions

Resectable Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage IIIA Lung Cancer AJCC v8

Stage IIIB Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Surgical Procedure

Cisplatin

Carboplatin

Pemetrexed

Gemcitabine

Colonoscopy

Recruiting

Sponsor:

NRG Oncology

Location:

Billings MT, Cody WY, Sheridan WY, Bozeman MTshow 297 more

Code:

NCT05080673

Conditions

Adenocarcinoma of the Colon

Adenocarcinoma of the Rectum

Eligibility Criteria

Sex: All

Age: 50 - 70

Healthy Volunteers: Not accepted

Interventions

5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy

Nivolumab, Ipilimumab, Cabozantinib

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Billings MT, Cody WY, Sheridan WY, Bozeman MTshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography Test

Remibrutinib vs. Teriflunomide

Recruiting
PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Billings MT, Salt Lake City UT, Boulder CO, Basalt COshow 62 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

Amivantamab-Subcutaneous

Recruiting
PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Billings MT, Bozeman MT, Great Falls MT, Missoula MTshow 85 more

Code:

NCT06116682

Conditions

Lung Non-Small Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Cancer Moonshot

Recruiting

Sponsor:

National Cancer Institute (NCI)

Location:

Billings MT, Lafayette CO, Brighton CO, Golden COshow 113 more

Code:

NCT04314401

Conditions

Acute Myeloid Leukemia

Anatomic Stage III Breast Cancer AJCC v8

Anatomic Stage IV Breast Cancer AJCC v8

Clinical Stage III Cutaneous Melanoma AJCC v8

Clinical Stage IV Cutaneous Melanoma AJCC v8

Eligibility Criteria

Sex: All

Age: 13+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Medical Chart Review

Nivolumab & Ipilimumab

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Billings MT, Bozeman MT, Great Falls MT, Anaconda MTshow 43 more

Code:

NCT05112601

Conditions

Endometrial Adenocarcinoma

Endometrial Clear Cell Adenocarcinoma

Endometrial Dedifferentiated Carcinoma

Endometrial Endometrioid Adenocarcinoma

Endometrial Mixed Cell Adenocarcinoma

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Ipilimumab

Magnetic Resonance Imaging

Nivolumab

Tivozanib & Pembrolizumab

Recruiting
PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Billings MT, Bozeman MT, Great Falls MT, Missoula MTshow 47 more

Code:

NCT06661720

Conditions

Clear Cell Renal Cell Carcinoma

Renal Cell Carcinoma (RCC)

Stage II Renal Pelvis Cancer AJCC v8

Stage III Renal Pelvis Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Tivozanib

Biospecimen Collection

MRI

Computed Tomography